Martha Sajatovic1, Curtis Tatsuoka2, Elisabeth Welter2, Daniel Friedman3, Tanya M Spruill4, Shelley Stoll5, Satya S Sahoo6, Ashley Bukach7, Yvan A Bamps8, Joshua Valdez9, Barbara C Jobst10. 1. Department of Psychiatry, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Department of Neurology, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. Electronic address: Martha.sajatovic@uhhospitals.org. 2. Department of Neurology, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. 3. Department of Neurology, New York University School of Medicine, New York, NY, United States. 4. Department of Population Health, New York University School of Medicine, NY, New York, United States. 5. Center for Managing Chronic Disease, University of Michigan, Ann Arbor, MI, United States. 6. Department of Neurology, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, United States; Department of Electrical Engineering and Computer Science, School of Medicine, Case Western Reserve University, Cleveland, OH, United States. 7. Department of Psychiatry, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Department of Neurology, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. 8. Emory University Rollins School of Public Health, Atlanta, GA, United States. 9. Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, United States. 10. Department of Neurology, Geisel School of Medicine at Dartmouth, Dartmouth College, Lebanon, NH, United States.
Abstract
RATIONALE: Epilepsy is a chronic neurological condition that causes substantial burden on patients and families. Quality of life may be reduced due to the stress of coping with epilepsy. For nearly a decade, the Centers for Disease Control (CDC) Prevention Research Center's Managing Epilepsy Well (MEW) Network has been conducting research on epilepsy self-management to address research and practice gaps. Studies have been conducted by independent centers across the U.S. Recently, the MEW Network sites, collaboratively, began compiling an integrated database to facilitate aggregate secondary analysis of completed and ongoing studies. In this preliminary analysis, correlates of quality of life in people with epilepsy (PWE) were analyzed from pooled baseline data from the MEW Network. METHODS: For this analysis, data originated from 6 epilepsy studies conducted across 4 research sites and comprised 459 PWE. Descriptive comparisons assessed common data elements that included gender, age, ethnicity, race, education, employment, income, seizure frequency, quality of life, and depression. Standardized rating scales were used for quality of life (QOLIE-10) and for depression (Patient Health Questionnaire, PHQ-9). RESULTS: While not all datasets included all common data elements, baseline descriptive analysis found a mean age of 42 (SD 13.22), 289 women (63.0%), 59 African Americans (13.7%), and 58 Hispanics (18.5%). Most, 422 (92.8%), completed at least high school, while 169 (61.7%) were unmarried, divorced/separated, or widowed. Median 30-day seizure frequency was 0.71 (range 0-308). Depression at baseline was common, with a mean PHQ-9 score of 8.32 (SD 6.04); 69 (29.0%) had depression in the mild range (PHQ-9 score 5-9) and 92 (38.7%) had depression in the moderate to severe range (PHQ-9 score >9). Lower baseline quality of life was associated with greater depressive severity (p<.001), more frequent seizures (p<.04) and lower income (p<.05). CONCLUSIONS: The MEW Network Integrated Database offers a unique opportunity for secondary analysis of data from multiple community-based epilepsy research studies. While findings must be tempered by potential sample bias, i.e. a relative under-representation of men and relatively small sample of some racial/ethnic subgroups, results of analyses derived from this first integrated epilepsy self-management database have potential to be useful to the field. Associations between depression severity and lower QOL in PWE are consistent with previous studies derived from clinical samples. Self-management efforts that focus on mental health comorbidity and seizure control may be one way to address modifiable factors that affect quality of life in PWE.
RATIONALE: Epilepsy is a chronic neurological condition that causes substantial burden on patients and families. Quality of life may be reduced due to the stress of coping with epilepsy. For nearly a decade, the Centers for Disease Control (CDC) Prevention Research Center's Managing Epilepsy Well (MEW) Network has been conducting research on epilepsy self-management to address research and practice gaps. Studies have been conducted by independent centers across the U.S. Recently, the MEW Network sites, collaboratively, began compiling an integrated database to facilitate aggregate secondary analysis of completed and ongoing studies. In this preliminary analysis, correlates of quality of life in people with epilepsy (PWE) were analyzed from pooled baseline data from the MEW Network. METHODS: For this analysis, data originated from 6 epilepsy studies conducted across 4 research sites and comprised 459 PWE. Descriptive comparisons assessed common data elements that included gender, age, ethnicity, race, education, employment, income, seizure frequency, quality of life, and depression. Standardized rating scales were used for quality of life (QOLIE-10) and for depression (Patient Health Questionnaire, PHQ-9). RESULTS: While not all datasets included all common data elements, baseline descriptive analysis found a mean age of 42 (SD 13.22), 289 women (63.0%), 59 African Americans (13.7%), and 58 Hispanics (18.5%). Most, 422 (92.8%), completed at least high school, while 169 (61.7%) were unmarried, divorced/separated, or widowed. Median 30-day seizure frequency was 0.71 (range 0-308). Depression at baseline was common, with a mean PHQ-9 score of 8.32 (SD 6.04); 69 (29.0%) had depression in the mild range (PHQ-9 score 5-9) and 92 (38.7%) had depression in the moderate to severe range (PHQ-9 score >9). Lower baseline quality of life was associated with greater depressive severity (p<.001), more frequent seizures (p<.04) and lower income (p<.05). CONCLUSIONS: The MEW Network Integrated Database offers a unique opportunity for secondary analysis of data from multiple community-based epilepsy research studies. While findings must be tempered by potential sample bias, i.e. a relative under-representation of men and relatively small sample of some racial/ethnic subgroups, results of analyses derived from this first integrated epilepsy self-management database have potential to be useful to the field. Associations between depression severity and lower QOL in PWE are consistent with previous studies derived from clinical samples. Self-management efforts that focus on mental health comorbidity and seizure control may be one way to address modifiable factors that affect quality of life in PWE.
Authors: Paul Ciechanowski; Naomi Chaytor; John Miller; Robert Fraser; Joan Russo; Jurgen Unutzer; Frank Gilliam Journal: Epilepsy Behav Date: 2010-07-06 Impact factor: 2.937
Authors: Jorge G Burneo; Nathalie Jette; William Theodore; Charles Begley; Karen Parko; David J Thurman; Samuel Wiebe Journal: Epilepsia Date: 2009-09-03 Impact factor: 5.864
Authors: Tracie A Caller; Robert J Ferguson; Robert M Roth; Karen L Secore; Faith P Alexandre; Wenyan Zhao; Tor Devin Tosteson; Patricia L Henegan; Kimberly Birney; Barbara C Jobst Journal: Epilepsy Behav Date: 2016-03-02 Impact factor: 2.937
Authors: Robin E McGee; Martha Sajatovic; Rakale C Quarells; Erika K Johnson; Hongyan Liu; Tanya M Spruill; Robert T Fraser; Mary Janevic; Cam Escoffery; Nancy J Thompson Journal: Epilepsy Behav Date: 2019-04-08 Impact factor: 2.937
Authors: James J Gugger; Eamonn Kennedy; Samin Panahi; David F Tate; Ali Roghani; Anne C Van Cott; M Raquel Lopez; Hamada Altalib; Ramon Diaz-Arrastia; Mary Jo Pugh Journal: Neurology Date: 2022-04-06 Impact factor: 11.800
Authors: Zaira Khalid; Hasina Momotaz; Farren Briggs; Kristin A Cassidy; Naomi S Chaytor; Robert T Fraser; Mary R Janevic; Barbara Jobst; Erica K Johnson; Peter Scal; Tanya M Spruill; Betsy K Wilson; Martha Sajatovic Journal: J Multidiscip Healthc Date: 2019-12-03
Authors: Mary Jo Pugh; Eamonn Kennedy; James J Gugger; Jamie Mayo; David Tate; Alicia Swan; Jacob Kean; Hamada Altalib; Shaila Gowda; Alan Towne; Sidney Hinds; Anne Van Cott; Maria R Lopez; Carlos A Jaramillo; Blessen C Eapen; Randall R McCafferty; Martin Salinsky; Joyce Cramer; Katherine K McMillan; Andrea Kalvesmaki; Ramon Diaz-Arrastia Journal: J Neurotrauma Date: 2021-10-15 Impact factor: 4.869